期刊文献+

SHIP基因真核表达载体的构建、鉴定及其表达抑制白血病细胞增殖的实验研究 被引量:1

Construction,Identification and Expression of Recombinant Eukaryotic Vector pCAG-IRES-SHIP-GFP on Porliferation of Leukemia Cell Line K562
原文传递
导出
摘要 构建真核表达载体pCAG-IRES-SHIP-GFP,并观察其在K562细胞中的表达。将SHIP逆转录聚合酶链反应(RT-PCR)产物克隆入pCAG-IRES-GFP,经酶切、PCR鉴定及测序分析,构建pCAG-IRES-SHIP-GFP重组真核表达载体;采用脂质体转染法将pCAG-IRES-SHIP-GFP及空载体转入K562细胞,实时荧光定量PCR(FQ-PCR)、Westernblot方法检测转染前后K562细胞中SHIPmRNA和蛋白的表达及Akt磷酸化水平改变,MTT、流式细胞仪检测等方法观察野生型SHIP基因表达对白血病细胞K562凋亡的影响。结果显示重组后的pCAG-IRES-SHIP-GFP质粒已成功载入SHIP的全长编码基因,序列测定的结果与预期设计完全一致。荧光显微镜下可见在转染pCAG-IRES-SHIP-GFP的K562细胞中存在荧光分布。外源性SHIP基因表达能使K562细胞增殖受抑;Westernblot检测提示K562细胞Akt308和Akt473的磷酸化水平较转染前显著下调,分别为转染前的38.7%和36.8%(P<0.01)。上述结果表明基因全长3.5kb的人野生型SHIP基因真核表达载体质粒pCAG-IRES-SHIP-GFP构建成功,并在K562细胞中表达;外源性SHIP基因表达能使K562细胞凋亡增加;这些改变可能与p-Akt表达下调有关。 The aim was to construct and identify the mammalian expression vector of pCAG-IRES-SHIP- GFP and to detect whether it could express in human acute leukemia cell line K562. The cDNA fragment of SHIP obtained by RT-PCR was inserted into pCAG-IRES-GFP. The recombinant plasmid was confirmed by restriction enzyme digesiton, PCR and DNA sequecing, pCAG-IRES-SHIP-GFP was transfected into K562 cells with lipofectamine 2000. The expression of SHIP was determined by GFP fluorescence and Western blot analysis. FQ -PCR was used to quantitate SHIP mRNA. The expression of p-Akt,Akt were determined by Western blot. PI were tested by flow cytometry and MTT to verify whether exogenous SHIP could inhibit proliferation of K562 cells. The results showed that the correct constrution of the recombinant plasmid pCAG-IRES-SHIP-GFP has been shown by restriction enzyme digestion, PCR and DNA sequencing, pCAG-IRES-SHIP-GFP could express SHIP protein in K562 cells. The K562 cells viability after transfected with SHIP gene droped down. Western blot analysis showed that phospha-Akt308 and Akt473 were reduced to 38. 7% and 68% respectively. It was concluded that the vector of pCAG-IRES-SHIP-GFP has been successfully constructed and it can be expressed in K562 cells. The expression of exogenous SHIP gene can lead to apoptosis of K562 cells by down-regulating the p -Akt expression. What found here might be one of the mechanisms involved in the pathogenesis of leukemia.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2009年第6期14-19,共6页 China Biotechnology
基金 国家自然科学基金(30240011) 河北省自然基金(2007000858)资助项目
关键词 pCAG4RES-SHIP-GFP 肌醇5′磷酸酶 基因转染 白血病 K562细胞 AKT磷酸化 细胞增殖 pCAG - IRES - SHIP - GF PSIHP Gene transfection Leukemia K562 cell p - Akt Proliferation
  • 相关文献

参考文献11

  • 1Geier S J,Algate P A,Carlberg K,et al.The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood.Blood,1997,89(6):1876-1885
  • 2Helgason C D,Antonchuk J,Bodner C,et al.Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice.Blood,2003,102(4):1541-1547
  • 3Luo J M,Yoshida H,Komura S,et al.Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.Leukemia,2003,17(1):1-8
  • 4罗建民,刘泽林,郝洪岭,王福旭,董作仁,大野竜三.急性白血病细胞SHIP基因的突变分析[J].中华血液学杂志,2004,25(7):385-388. 被引量:13
  • 5张苏江,李建勇,施静艺,史占中,顾柏炜,白雪涛,朱勇梅,沈志祥.急性髓系白血病患者PDGFRβ和SHIP基因突变及其单核苷酸多态性研究[J].中华血液学杂志,2006,27(6):383-385. 被引量:11
  • 6刘小军,罗建民,杨琳,温树鹏,姚丽,杜行严,杨敬慈,董作仁.慢性粒细胞性白血病中SHIP1基因的表达变化及机制探讨[J].解放军医学杂志,2008,33(6):701-703. 被引量:10
  • 7任金海,罗建民,杨敬慈,杜行严,姚丽,尚银涛,刘小军.白血病细胞内SHIP基因表达及其对AKT磷酸化的影响[J].中华血液学杂志,2007,28(12):844-845. 被引量:9
  • 8Kisseleva M V,Cao L,Majerus P W,et al.Phosphoinositide-specific inositol phlyphosphate 5-phosphatase Ⅳ inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death.J Biol Chem,2002,277(8):6266-6272
  • 9Aggerholm A,Gronbaek K,Guldberg P,et al.Mutational analysis of the tumor suppressor gene MMAC1/PTEN in malignant myeloid disorders.Eur J Haematol,2000,65(2):109-113
  • 10Yang J,Liu J,Zheng J,et al.A reappraisal by quantitative flow cytometry analysis of PTEN expression in acute leukemia.Leukemia.2007,21(9):2072-2074

二级参考文献29

  • 1罗建民,刘泽林,郝洪岭,王福旭,董作仁,大野竜三.急性白血病细胞SHIP基因的突变分析[J].中华血液学杂志,2004,25(7):385-388. 被引量:13
  • 2Kelly LM,Gilliland DG.Genetics of myeloid leukemias.Annu Rev Genomics Hum Genet,2002,3:179-198.
  • 3Vardiman JW,Harris NL,Brunning RD.The World Health Organization (WHO) classification of the myeloid neoplasms.Blood,2002,100:2292-2302.
  • 4Steer E J,Cross NC.Myeloproliferative disorders with translocations of chromosome 5q31-35:role of the platelet-derived growth factor receptor Beta.Acta Haematol,2002,107:113-122.
  • 5Apperley JF,Gardembas M,Melo JV,et al.Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.N Engl J Med,2002,347:481-487.
  • 6Odai H,Sasaki K,Iwamatsu A,et al.Purification and molecular cloning of SH2-and SH3-containing inositol polyphosphate-5-phosphatase,which is involved in the signaling pathway of granulocytemacrophage colony-stimulating factor,erythropoietin,and Bcr-Abl.Blood,1997,89:2745-2756.
  • 7Luo JM,Yoshida H,Komura S,et al.Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.Leukemia,2003,17:1-8.
  • 8Tartaglia M,Niemeyer CM,Fragale A,et al.Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia,myelodysplastic syndromes and acute myeloid leukemia.Nature Genet,2003,34:148-150.
  • 9Skorski T.Oncogenic tyrosine kinases and the DNA-damage response.Nat Rev Cancer,2002,2:351-360.
  • 10Geier SJ, Algate PA, Carlberg K, et al. The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood. Blood, 1997,89 : 1876-1885.

共引文献18

同被引文献13

  • 1罗建民,刘泽林,郝洪岭,王福旭,董作仁,大野竜三.急性白血病细胞SHIP基因的突变分析[J].中华血液学杂志,2004,25(7):385-388. 被引量:13
  • 2张之南,沈悌.血液病诊断及疗效标准[M].北京:科学出版社,2008.103-122,131-134,172-176.
  • 3Rohrschneider LR,Fuller JF,Wolf I,et al.Structure,function,and biology of SHIP proteins[J].Genes Dev,2000,14(5):505-520.
  • 4Luo JM,Yoshida H,Komura S,et al.Possible dominant-negative mutation of the SHIP gene in acute myeloidleukemia[J].Leukemia,2003,17(1):1-8.
  • 5Jian Y,Dunbar A,Gondek LP,et al.Aberrant DNAmethylation is a dominant mechanism in MDS progression toAML[J].Blood,2009,113(6):1315-1325.
  • 6Lee DW,Futami M,Carroll M,et al.Loss of SHIP-1protein expression in high-risk myelodysplastic syndromes isassociated with miR-210and miR-155[J].Oncogene,2012,31(37):4085-4094.
  • 7Kedar R,Sabag O,Licthenstein M,et al.Soluble CD40ligand(sCD40L)provides a new delivery system for targetedtreatment:sCD40L-Caspase 3 chimeric protein for treatingB-cell malignancies[J].Cancer,2012,118(24):6089-6104.
  • 8尚振川,宋霆婷,孙秉中,侯严堂,冯琦,张涛,邓涛.caspase-3在慢性粒细胞白血病信号转导中的作用[J].中华实用诊断与治疗杂志,2009,23(1):44-46. 被引量:4
  • 9李晓花,薛天阳,许伟,高吉照.Caspase3在MG-132诱导白血病L1210细胞凋亡过程中的作用[J].中国小儿血液与肿瘤杂志,2010,15(3):112-114. 被引量:6
  • 10王淋淋,高冲,陈宝安.MDS转化为AML机制的研究进展[J].中国实验血液学杂志,2011,19(1):254-259. 被引量:11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部